Chief Medical Strategy Officer @ (November 2025 - Present)
Consultant, Oncology Drug Development @ (October 2025 - February 2026)
Oncology Medical Strategy Advisor @ (January 2025 - January 2026)
Vice President, Oncology Drug Development Solutions, Scientific and Medical Affairs @ (January 2022 - November 2024)
Senior Scientific Director, Cell Therapy and Redirected Immunity, Oncology Clinical Science @ (August 2020 - January 2022)
Director, Medical Affairs Strategy Lead, US Oncology Health Systems @ (September 2018 - July 2020)
Associate Director, Oncology Global Regulatory Affairs @ (April 2017 - September 2018)
Associate Director and Principal Clinical Research Scientist Oncology @ (October 2007 - March 2017)
Director of Research @ (May 2003 - September 2007)
Research Assistant Professor @ (February 2001 - May 2003)
NIH Postdoctoral Research Fellow @ Cancer Research Center, Washington State University (January 1999 - June 2000)
Tanja Obradovic Education
University of Belgrade
Bachelor of Science - BS (Molecular Biology and Physiology)
Washington State University
Doctor of Philosophy - PhD (Pharmacology and Toxicology)
Tanja Obradovic Summary
Tanja Obradovic, based in Dresher, PA, US, is currently a Vice President, Medical and Scientific Strategy, Oncology at Novotech. Tanja Obradovic brings experience from previous roles at Novotech, HopeAI, Arc Nouvel Clinical Development Consulting LLC and Mercurial AI. Tanja Obradovic holds a Bachelor of Science - BS in Molecular Biology and Physiology @ University of Belgrade. Tanja Obradovic has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Tanja Obradovic?
Find contact details for 700 million professionals.